Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 1
1996 3
1997 1
1998 2
1999 5
2000 2
2001 4
2002 2
2003 3
2004 1
2005 5
2006 9
2007 5
2008 7
2009 8
2010 9
2011 14
2012 22
2013 23
2014 21
2015 24
2016 20
2017 20
2018 28
2019 18
2020 43
2021 40
2022 45
2023 43
2024 12

Text availability

Article attribute

Article type

Publication date

Search Results

387 results

Results by year

Filters applied: . Clear all
Page 1
Optimal managements of elderly patients with glioblastoma.
Arakawa Y, Mineharu Y, Uto M, Mizowaki T. Arakawa Y, et al. Among authors: mizowaki t. Jpn J Clin Oncol. 2022 Aug 5;52(8):833-842. doi: 10.1093/jjco/hyac075. Jpn J Clin Oncol. 2022. PMID: 35552425 Free PMC article. Review.
[Stereotactic body radiotherapy (SBRT)].
Nagata Y, Takayama K, Matsuo Y, Norihisa Y, Mizowaki T, Sakamoto M, Yano S, Narita Y, Yamamoto T, Hiraoka M. Nagata Y, et al. Among authors: mizowaki t. Gan To Kagaku Ryoho. 2006 Apr;33(4):455-61. Gan To Kagaku Ryoho. 2006. PMID: 16612153 Review. Japanese.
Novel approach of prophylactic radiation to reduce toxicities comparing 2-step40 with 56-Gy simultaneous integrated boost intensity-modulated radiation therapy for locally advanced squamous cell carcinoma of the head and neck, an intergroup phase III trial (JCOG1912, NEW BRIDGE).
Yokota T, Zenda S, Kodaira T, Kiyota N, Fujimoto Y, Wasano K, Takahashi R, Mizowaki T, Homma A, Sasaki K, Machida R, Sekino Y, Fukuda H; Japan Clinical Oncology Group Radiation Therapy Study Group; Japan Clinical Oncology Group Head and Neck Cancer Study Group. Yokota T, et al. Among authors: mizowaki t. BMC Cancer. 2023 Nov 6;23(1):1068. doi: 10.1186/s12885-023-11503-z. BMC Cancer. 2023. PMID: 37932681 Free PMC article. Clinical Trial.
Recurrence patterns and progression-free survival after chemoradiotherapy with or without consolidation durvalumab for stage III non-small cell lung cancer.
Kishi N, Matsuo Y, Shintani T, Ogura M, Mitsuyoshi T, Araki N, Fujii K, Okumura S, Nakamatsu K, Kishi T, Atsuta T, Sakamoto T, Ohtsu S, Katagiri T, Narabayashi M, Fujishiro S, Iizuka Y, Ozasa H, Hirai T, Mizowaki T; Kyoto Radiation Oncology Study Group (KROSG). Kishi N, et al. Among authors: mizowaki t. J Radiat Res. 2023 Jan 20;64(1):142-153. doi: 10.1093/jrr/rrac057. J Radiat Res. 2023. PMID: 36149029 Free PMC article.
A phase III randomized controlled trial comparing local field with additional prophylactic irradiation in chemoradiotherapy for clinical-T1bN0M0 esophageal cancer: ARMADILLO trial (JCOG1904).
Sasaki K, Nomura M, Kato K, Sakanaka K, Ito Y, Kadota T, Machida R, Kataoka T, Minashi K, Tsubosa Y, Kajiwara T, Fukuda H, Takeuchi H, Mizowaki T, Nishimura Y, Kitagawa Y. Sasaki K, et al. Among authors: mizowaki t. Jpn J Clin Oncol. 2024 Jan 7;54(1):103-107. doi: 10.1093/jjco/hyad137. Jpn J Clin Oncol. 2024. PMID: 37801434 Clinical Trial.
387 results